Glad and honored to participate in the 5th Cholangiocarcinoma International Expert Meeting and in the 4th #APIC National (Italian) Meeting in Verona. #CCA #BTC

From @theathletic.com: What a comeback from Amber Glenn. The American figure skater had a nearly flawless routine in her free skate after her disappointing women’s short program. “What a brilliant, redemptive skate. She just fought so hard.” nyti.ms/4arq55z

I wrote this song on Saturday, recorded it yesterday and released it to you today in response to the state terror being visited on the city of Minneapolis. It’s dedicated to the people of Minneapolis, our innocent immigrant neighbors and in memory of Alex Pretti and Renee Good. Stay free

@acammarota.bsky.social presenting her work on clinical predictors and molecular architecture of #TLS in #CCA 🔬at @easlnews.bsky.social #LiverCancerSummit in Edinburgh. Great job! 👏🏻👏🏻👏🏻 #AnaLleo #HumanitasUniversity #Humanitas

We’re in for an engaging hour with an international & multidisciplinary hepatobiliary tumor board tackling complex HCC cases during the #GI26 “Liver Power Hour” chaired by Dr. Riad Salem & Dr. Nina Niu Sanford. #hpbcsm meetings.asco.org/meetings/202... @lorenzarimassa.bsky.social

Early morning start at @ascocancer.bsky.social #GI26 in San Francisco. Excited to meet friends and colleagues and discuss treatment options for patients with #HCC #CCA #BTC #PDAC #HumanitasUniversity #Humanitas

Traveling to Singapore for #ESMOAsia25. Looking forward to meeting with friends and colleagues and discussing new therapeutic options for patients with #GI cancers #HCC #CCA #BTC @myesmo.bsky.social

Please have a look at our editorial published in #ASCODailyNews @ascocancer.bsky.social @antoniodalessio.bsky.social @cirocelsa.bsky.social From Sorafenib to Precision Medicine: The Future of Systemic Therapy in Hepatocellular Carcinoma dailynews.ascopubs.org/do/sorafenib...

Oral presentations on biliary tract cancer at AIOM | Associazione Italiana di Oncologia Medica annual congress. Congratulations to Chiara Pirrone and Virginia Genovesi for their studies on #BTC #CCA!

🤖 How can generative and foundation models reshape oncology, - from research to clinical practice? Find out in the session “Generative AI” at #ESMOAI25 in Berlin. 👉 www.esmo.org/meeting-cale...

JulieHeimbach discusses #livertransplant for patients with intrahepatic or perihilar #cholangiocarcinoma #CCA at the Advances in Hepatology Symposium in Berlin #FalkFoundation

🎥 50 years of key moments. ESMO’s 50th anniversary marks decades of achievements in #ScienceDissemination, #education and #collaboration. Take a selfie and share one of your milestones with #myESMOStory. #ESMO25 🔗 www.youtube.com/watch?v=dJTH...

@myesmo.bsky.social is where everything began, my first international oral presentation as a resident in medical oncology, my first international role as chair, discussant, invited speaker. I will always be grateful to #ESMO! #myESMOStory #ESMO25 #ESMOAmbassadors

It’s great to see a friend and colleague growing within @myesmo.bsky.social! #ESMO25 #myESMOStory #ESMOAmbassadors

James Harding presents phase 1 data showing a manageable safety profile and promising efficacy in advanced #PDAC at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

🎉 Your #myESMOStory moments made ESMO’s 50th anniversary special. From selfies at #ESMO25 to memories shared from afar, together we marked 50 years of progress in oncology. Here’s to accelerating impact! #ONEoncologycommunity

Do-Youn Oh discusses abstracts on #biliary tract cancer #BTC #CCA orally presented at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Michele Reni presents novel findings from the #CASSANDRA phase 3 study of perioperative treatment in #PDAC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

IMMUNOBIL phase 2 study of immunotherapy #STRIDE for patients with previously treated advanced #BTC #CCA. Negative study but a subgroup of patients seem to benefit, we need biomarkers. #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Phase 2-3 ZSAB-neoGOLP trial of #neoadjuvant GOLP regimen for resectable i#CCA with high-risk features for recurrence. A positive interim analysis, but not a standard regimen. Novel approaches are needed. #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Milind Javle presents the results of #tinengotinib in patients with #CCA #BTC and #FGFR2 gene fusions previously treated with other FGFR inhibitors at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

@arndtvogel.bsky.social discusses #ABC-HCC and #TALENTop studies and puts them into the context. Positive studies, potential novel strategies, still open questions. Key message, #MDT is key in the management of patients with #HCC. #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Hui-Chuan Sun presents the #TALENTop phase 3 study of atezolizumab-bevacizumab followed by surgery in locally advanced #HCC. Positive study, #MDT discussion is key! #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Peter Galle presents ABC-HCC, academic study of atezolizumab-bevacizumab vs TACE for intermediate stage #HCC. Improved time to failure of treatment strategy with #systemic therapy. Positive study, potential novel approach for #intermediate HCC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Interested in or worried about #LargeLanguageModels in #ClinicalPractice? The @myesmo.bsky.social Guidance (#ELCAP) is out and ready for download! #ESMO25 #ESMOAmbassadors

The ESMO Guidance on the use of #LargeLanguageModels in #ClinicalPractice (#ELCAP) is out: the first structured set of recommendations to bring #AI language models into #oncology safely and effectively. #ESMOAI25 #ESMO25 #LLMs #HealthAI 🔗 buff.ly/pg1gkiU

Stephen L. Chan discusses #CARES-009 and #SKYSCRAPER-14 phase 3 studies in #HCC at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

CARES-009 phase 3 study of perioperative camrelizumab and rivoceranib for #HCC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Richard Finn presents the results of phase 3 IMbrave152/SkYSCRAPER-14 study at #ESMO25 Anti-TIGIT tiragolumab does not add benefit to atezolizumab-bevacizumab for patients with advanced #HCC #ESMOAmbassadors @myesmo.bsky.social

HRS-4642 combined with chemo in advanced #KRAS-G12D mutant #PDAC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Breaking the boundaries in pancreatic cancer #PDAC #surveillance #risk #liquidbiopsy #ctDNA #KRAS #noveltherapies #ESMO25 #ESMOAmbassadors @benwestphalen.bsky.social @myesmo.bsky.social

🤝 #Mentorship is key for the #CareerDevelopment of #OncologyProfessionals. #myESMOStory Join us for a Mentor the Mentor session at #ESMO25! 📅 Saturday, 18 October 2025 | 11:30 – 12:30 | 📍 Erfurt Auditorium – CityCube A 🔗 https://ow.ly/PWWx50XbxHM

Matteo Simonelli presents the results for MK-1084 monotherapy in patients with #KRAS #G12C-mutated advanced solid tumors enrolled in the #phase1 KANDLELIT-001 study at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Please join the @myesmo.bsky.social Climate Change Task Force session on Saturday to learn more about climate conscious cancer care. #ESMO4Climate #ESMO25 #ESMOAmbassadors

On my way to #ESMO25! I look forward to meeting friends and colleagues and discussing new data on hepatobiliary cancer #HCC #CCA #BTC. #ESMOAmbassadors @myesmo.bsky.social

📸 It is time for you to be a part of it: Share your #myESMOStory at #ESMO25. 🤳Find our selfie spots across the Congress venue and snap a photo—alone or with your team. 🔗 www.esmo.org/about-esmo/5...

At #ESMO25, explore how AI & digital tools are shaping oncology: 📌 AI-based image biomarkers 📌 Clinical trials in the age of AI 📌 Digital tools for off-site care 📌 ChatGPT & cancer care 📅 17–19 Oct

Tumour-agnostic therapies: ready for prime time? How do we accelerate adoption? At #ESMO25, follow two sessions on: Approved & emerging agnostic therapies Biomarkers & precision strategies Clinical, statistical & regulatory perspectives 18 & 20 Oct 🔗 https://ow.ly/VwE350XbbHy

👩‍⚕️ Young Oncologists at #ESMO25: mentorship, masterclasses, clinical cases, brunch sessions, Vesalius Talk, and more! Learn, connect, and grow from 17–20 Oct 🔗 https://ow.ly/BcZT50XaX79

Rolf Stahel, recipient of the 2025 ESMO Lifetime Achievement Award, will deliver his Award lecture at the #ESMO25 Opening Session, highlighting a career of impactful leadership in #ClinicalResearch, education, and international collaboration in oncology. 📅Don’t miss it 👉 https://ow.ly/IqFp50XceqP

Beyond immune checkpoint blockade: what’s next for #melanoma? At #ESMO25, explore: 📌 Why move beyond ICB 📌 #AdoptiveCellTherapy 📌 Treating unresectable stage IV melanoma 📌 Bispecific T-cell engagers 📅 17 Oct | 14:00–15:30 🔗 buff.ly/RaDTAFV

Glenda Ramos Martinez will receive the inaugural Oncologist of the Year Award for advancing oncology in Ecuador, expanding continuing medical education, and advocating for improved access to #CancerMedicines.

🔔 Heads up: the Late Breaking Abstracts of #ESMO25 will be available online at 00:05 on the day of their presentation. Stay tuned for the latest research breakthroughs and clinical changes in #oncology.

Thousands gather in London in march for ‘lasting peace’ in Gaza

Diane Keaton, Oscar-winning star of Annie Hall and The Godfather, dies aged 79

Already registered for #ESMO25? Your Virtual Congress Bag is waiting! 📂 Access, view, and download all the essential materials designed to make your congress experience even better. Get your congress bag today! 🔗 https://ow.ly/XMXL50X96wY

📸 What is your #myESMOStory? Share a group photo and tell us. Use #myESMOStory, tag ESMO and those who shaped your #ProfessionalPath. #ESMO25 🔗 ow.ly/SWfE50X8mFJ

📸 Tell us your #myESMOStory with a selfie. Do not forget to tag those who have been part of your journey. #ESMO25 #ONEoncologycommunity 🔗 ow.ly/xsOA50X8nzt

#ESMO25: Do not miss the latest findings in #CancerResearch brought to you by the #ESMOAmbassadors & become part of the conversation in #oncology. 🔗 ow.ly/Tkr850X9A1a

The full ENDURO report has just been published at @LancetGastroHep - www.thelancet.com/journals/lan... #GastroSky #MedSky #UEGWeek